Clinical Trial Update: Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema [Phase 1]

View source ↗

Summary

Reports the completion and results posting of a Phase 1 pilot trial evaluating ranibizumab (Lucentis) for uveitic cystoid macular edema. The study was sponsored…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitic Cystoid Macular Edema

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: University of Miami | Conditions: Uveitic Cystoid Macular Edema | Phase 1 | Status: COMPLETED | Results posted: 2014-08-26